Chondronecrosis of the cricoid treated with hyperbaric oxygen therapy: A case series | Canada Hyperbarics Skip to main content
Study Undersea Hyperb Med 2024

Chondronecrosis of the cricoid treated with hyperbaric oxygen therapy: A case series

Spencer J, Connely T, Cooper J, Dowdall J — Undersea Hyperb Med, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

US physicians reported two cases of patients who developed dying cartilage in the voice box (cricoid chondronecrosis) after being on breathing tubes, both of whom were treated with HBOT after tracheostomy and antibiotics.

What They Found

Both patients completed at least 20 HBOT sessions and were successfully removed from their tracheostomy tubes within six months of starting treatment. The authors note HBOT likely helped by reducing swelling, promoting new blood vessel growth, boosting antibiotic effectiveness, and supporting immune function in oxygen-deprived tissue.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

A case series of only two patients cannot establish HBOT as effective, these outcomes could reflect natural recovery, antibiotics, or other factors.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 38615354
Year Published 2024
Journal Undersea Hyperb Med
MeSH Terms Humans; Hyperbaric Oxygenation; Oxygen; Research; Physicians; Anti-Bacterial Agents

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.